Impact of Residual Renal Function on Complications in Chronic Hemodialysis Patients
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Our aim is to study the impact of residual renal function on hemodialysis patients mortality and morbidity .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2019
CompletedFirst Posted
Study publicly available on registry
February 26, 2019
CompletedStudy Start
First participant enrolled
February 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2020
CompletedFebruary 26, 2019
February 1, 2019
12 months
February 14, 2019
February 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
determine complications of hemodialysis on patients with chronic kidney disease
impact of residual renal function on hemodialysis patients mortality and morbidity and imprtance of high residual renal function on patients lifespan \- residual renal function will assess by GFR which assess by MDRD and creatinine clearance methods
baseline
Study Arms (2)
-Group 1 (anuric)
patients on maintenance hemodialysis after 6 months to 1 year or more and urinary output less than 100ml / day
Group 2 (good UOP)
patients on maintenance hemodialysis after 6 months to 1 year or more and urinary output 400ml / day or more
Interventions
A machine used in dialysis that filters a patient's blood to remove excess water and waste products when the kidneys are damaged
Eligibility Criteria
any populatin
You may qualify if:
- Chronic renal failure patients on maintenance hemodialysis after at least six months.
You may not qualify if:
- Obstructive uropathy.
- Heart failure.
- Chronic liver disease( decompensated liver cirrhosis and ascites).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Hu SL, Joshi P, Kaplan M, Lefkovitz J, Poenariu A, Dworkin LD, Michaud DS. Rapid Change in Residual Renal Function Decline Is Associated with Lower Survival and Worse Residual Renal Function Preservation in Peritoneal Dialysis Patients. Perit Dial Int. 2017 Jul-Aug;37(4):477-481. doi: 10.3747/pdi.2016.00211.
PMID: 28676514BACKGROUNDCho HY, Hyun HS, Kang HG, Ha IS, Cheong HI. Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis. Perit Dial Int. 2013 Jul-Aug;33(4):398-404. doi: 10.3747/pdi.2011.00246. Epub 2012 Dec 3.
PMID: 23209039BACKGROUNDMaksic D, Colic M, Stankovic-Popovic V, Radojevic M, Bokonjic D. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis. Med Pregl. 2007;60 Suppl 2:53-7.
PMID: 18928158BACKGROUNDKazmi WH, Gilbertson DT, Obrador GT, Guo H, Pereira BJ, Collins AJ, Kausz AT. Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis. 2005 Nov;46(5):887-96. doi: 10.1053/j.ajkd.2005.08.005.
PMID: 16253729BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohammed A. Sobh
Assuit Univeristy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 14, 2019
First Posted
February 26, 2019
Study Start
February 26, 2019
Primary Completion
February 15, 2020
Study Completion
April 20, 2020
Last Updated
February 26, 2019
Record last verified: 2019-02